- Home
- ARBE vs XGN Comparison
ARBE vs XGN Comparison
Compare ARBE & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBE | XGN |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.9M | 138.9M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARBE | XGN |
|---|---|---|
| Price | $1.17 | $6.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $1.75 | ★ $13.67 |
| AVG Volume (30 Days) | ★ 3.1M | 295.4K |
| Earning Date | 11-17-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $667,000.00 | ★ $63,599,000.00 |
| Revenue This Year | $69.79 | $21.76 |
| Revenue Next Year | $576.46 | $15.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.08 |
| 52 Week Low | $0.85 | $2.67 |
| 52 Week High | $5.09 | $12.23 |
Technical Indicators
Market Signals| Indicator | ARBE | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.03 | 28.31 |
| Support Level | $1.12 | $5.84 |
| Resistance Level | $1.27 | $6.34 |
| Average True Range (ATR) | 0.09 | 0.33 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 46.52 | 18.97 |
Price Performance
Historical ComparisonAbout ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.